We serve Chemical Name:Methyl 5-bromo-6-chloro-1H-indazole-4-carboxylate CAS:1037841-34-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Methyl 5-bromo-6-chloro-1H-indazole-4-carboxylate
CAS.NO:1037841-34-1
Synonyms:5-Bromo-6-chloro-1H-indazole-4-carboxylic acid methyl ester
Molecular Formula:C9H6BrClN2O2
Molecular Weight:289.51300
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:54.98000
Exact Mass:287.93000
LogP:2.76540
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 5-Bromo-6-chloro-1H-indazole-4-carboxylic acid methyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-Bromo-6-chloro-1H-indazole-4-carboxylic acid methyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-Bromo-6-chloro-1H-indazole-4-carboxylic acid methyl ester Use and application,5-Bromo-6-chloro-1H-indazole-4-carboxylic acid methyl ester technical grade,usp/ep/jp grade.
Related News: The company forecasts that the 70-strong team will grow by around 50% in the next three years to support its clinical and commercial API manufacturing capabilities. 1-(2-methyl-4,5-disulfophenyl)-5-oxo-4,5-dihydro-1H-pyrazole-3-carboxylic acid manufacturers Earlier this year, the company revealed it had broken ground on a 38,000-square-foot commercial cell therapy plant in Lexington, Massachusetts, which is about 10 miles from downtown Boston. Takeda says the new $84 million plant will be used to make cell therapies for cancers and other diseases. 2,3,5,6-tetra-O-acetyl-1-O-benzyl-4-O-(2,3,4,5,6-penta-O-acetyl-1-deoxy-D-galactitol-1-yl)-D-glucitol suppliers UQUIFA is a manufacturer of APIs and intermediates for the pharmaceutical industry globally. The company has 3 manufacturing sites (2 in Spain and 1 in Mexico) with strict adherence to all regulatory norms. 4-methylhex-5-enal vendor & factory According to Plexxikon, GSK scientists were only able to make Tafinlar after talks with Plexxikon about a potential partnership; although those talks never turned into a licensing deal, GSK apparently channeled that information and created a rival drug.,The company forecasts that the 70-strong team will grow by around 50% in the next three years to support its clinical and commercial API manufacturing capabilities.
